InMode Ltd.
INMDNasdaq
$15.47
↓ -0.8%Jul 17 close · end-of-day
Price
1Y↑ +8.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.0B
Enterprise Value
$626.3M
P/E
10.8
P/S
2.7
P/B
1.5
EV/EBITDA
7.3
PEG
—
FCF Yield
8.3%
Dividend Yield
—
Revenue (TTM)
$370.5M
Net Income (TTM)
—
Free Cash Flow (TTM)
$84.3M
Gross Margin
78.5%
Operating Margin
23.1%
Net Margin
—
ROE
—
ROIC
24.4%
Debt / Equity
—
Net Cash
$386.2M
Return 1Y
+9.7%
Company profile
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company was formerly known as Invasix Ltd. and changed its name to In Mode Ltd. in November 2017.
- CEO
- Moshe Mizrahy
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 480
- Website
- inmodemd.com
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $206.1M | $357.6M | $454.3M | $492.0M | $394.8M | $370.5M |
| Gross profit | $175.3M | $304.0M | $380.8M | $411.3M | $317.1M | $291.0M |
| Operating income | $72.8M | $167.5M | $197.9M | $195.7M | $112.5M | $85.4M |
| Net income | $75.0M | $165.0M | $161.5M | $197.9M | — | — |
| Diluted EPS | $0.89 | $1.92 | $1.89 | $2.30 | $2.25 | $1.43 |
| Operating cash flow | $79.2M | $174.9M | $181.6M | $176.8M | $132.7M | $85.3M |
| Free cash flow | $78.8M | $173.9M | $180.0M | $176.1M | $132.0M | $84.3M |
| Gross margin | 85.0% | 85.0% | 83.8% | 83.6% | 80.3% | 78.5% |
| Operating margin | 35.3% | 46.8% | 43.6% | 39.8% | 28.5% | 23.0% |
| Net margin | 36.4% | 46.1% | 35.6% | 40.2% | — | — |
No quarterly data.
Company news
Jul 13, 2026
- 7d agoExchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Renewed US-Iran Conflict Lifts Oil Pricesfinance.yahoo.com
- 7d agoInMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375Mfinance.yahoo.com
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.